Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1985 2
1989 1
1990 2
1992 2
1993 2
1994 1
1996 3
2000 1
2001 1
2002 2
2004 1
2005 1
2006 1
2007 3
2008 3
2009 3
2010 4
2011 3
2012 2
2013 1
2014 3
2015 5
2016 6
2017 3
2018 3
2019 3
2020 11
2021 17
2022 15
2023 18
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Results by year

Filters applied: . Clear all
Page 1
Molecular investigation of candidate genes for pyroptosis-induced inflammation in diabetic retinopathy.
Wang N, Ding L, Liu D, Zhang Q, Zheng G, Xia X, Xiong S. Wang N, et al. Front Endocrinol (Lausanne). 2022 Jul 25;13:918605. doi: 10.3389/fendo.2022.918605. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35957838 Free PMC article.
BACKGROUND: Diabetic retinopathy is a diabetic microvascular complication. ...Among them, CASP4, GBP1, CASP3, TLR4, and GBP2 were further validated in the GSE179568 dataset. Finally, 20 miRNAs were predicted to target three key genes-CASP3, GBP2, and T …
BACKGROUND: Diabetic retinopathy is a diabetic microvascular complication. ...Among them, CASP4, GBP1, CASP3, TLR4, and …
Fenofibrate for diabetic retinopathy.
Kataoka SY, Lois N, Kawano S, Kataoka Y, Inoue K, Watanabe N. Kataoka SY, et al. Cochrane Database Syst Rev. 2023 Jun 13;6(6):CD013318. doi: 10.1002/14651858.CD013318.pub2. Cochrane Database Syst Rev. 2023. PMID: 37310870 Review.
BACKGROUND: Diabetic retinopathy (DR) remains a major cause of sight loss worldwide, despite new therapies and improvements in the metabolic control of people living with diabetes. ...SELECTION CRITERIA: We included randomised controlled trials (RCTs) that in …
BACKGROUND: Diabetic retinopathy (DR) remains a major cause of sight loss worldwide, despite new therapies and improvem …
Performance and Limitation of Machine Learning Algorithms for Diabetic Retinopathy Screening: Meta-analysis.
Wu JH, Liu TYA, Hsu WT, Ho JH, Lee CC. Wu JH, et al. J Med Internet Res. 2021 Jul 3;23(7):e23863. doi: 10.2196/23863. J Med Internet Res. 2021. PMID: 34407500 Free PMC article. Review.
BACKGROUND: Diabetic retinopathy (DR), whose standard diagnosis is performed by human experts, has high prevalence and requires a more efficient screening method. ...The performance of ML in detecting more-than-mild DR was robust (sensitivity 0.95; AUROC 0.97 …
BACKGROUND: Diabetic retinopathy (DR), whose standard diagnosis is performed by human experts, has high prevalence and …
Association between diabetic retinopathy and interleukin-related gene polymorphisms: a machine learning aided meta-analysis.
Sun X, Guo S. Sun X, et al. Ophthalmic Genet. 2020 Jun;41(3):216-222. doi: 10.1080/13816810.2020.1747091. Epub 2020 Apr 13. Ophthalmic Genet. 2020. PMID: 32281460 Review.
BACKGROUND: Diabetic retinopathy (DR) is a severe complication of diabetes and a common cause of visual loss in adults. ...Mutations in multiple SNPs for each DR patient still need to be specifically assessed to increase prediction accuracy....
BACKGROUND: Diabetic retinopathy (DR) is a severe complication of diabetes and a common cause of visual loss in adults. …
Potential disease biomarkers for diabetic retinopathy identified through Mendelian randomization analysis.
Zou X, Ye S, Tan Y. Zou X, et al. Front Endocrinol (Lausanne). 2024 Jan 11;14:1339374. doi: 10.3389/fendo.2023.1339374. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38274229 Free PMC article.
BACKGROUND: Diabetic retinopathy (DR), a leading cause of vision loss, has limited options for effective prevention and treatment. ...RESULTS: Our MR analysis identified significant associations of specific plasma proteins with DR and proliferative DR (PDR). …
BACKGROUND: Diabetic retinopathy (DR), a leading cause of vision loss, has limited options for effective prevention and …
Diabetic Retinopathy Prediction by Ensemble Learning Based on Biochemical and Physical Data.
Shen Z, Wu Q, Wang Z, Chen G, Lin B. Shen Z, et al. Sensors (Basel). 2021 May 25;21(11):3663. doi: 10.3390/s21113663. Sensors (Basel). 2021. PMID: 34070287 Free PMC article.
(1) Background: Diabetic retinopathy, one of the most serious complications of diabetes, is the primary cause of blindness in developed countries. Therefore, the prediction of diabetic retinopathy has a positive impact on its early detection and treatm …
(1) Background: Diabetic retinopathy, one of the most serious complications of diabetes, is the primary cause of blindn …
Relationship between dyslipidemia and diabetic retinopathy in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
Li Z, Yuan Y, Qi Q, Wang Q, Feng L. Li Z, et al. Syst Rev. 2023 Aug 24;12(1):148. doi: 10.1186/s13643-023-02321-2. Syst Rev. 2023. PMID: 37620980 Free PMC article. Review.
BACKGROUND: Diabetic retinopathy (DR) affects more than 80% of patients with diabetes. ...Higher levels of total cholesterol (2.94 mg/dL, 95% CI 1.32, 4.56), triglycerides (8.13 mg/dL, 95% CI 5.59, 10.66), and low-density lipoprotein cholesterol (2.53 mg/dL, …
BACKGROUND: Diabetic retinopathy (DR) affects more than 80% of patients with diabetes. ...Higher levels of total choles …
Identify diabetic retinopathy-related clinical concepts and their attributes using transformer-based natural language processing methods.
Yu Z, Yang X, Sweeting GL, Ma Y, Stolte SE, Fang R, Wu Y. Yu Z, et al. BMC Med Inform Decis Mak. 2022 Sep 27;22(Suppl 3):255. doi: 10.1186/s12911-022-01996-2. BMC Med Inform Decis Mak. 2022. PMID: 36167551 Free PMC article.
BACKGROUND: Diabetic retinopathy (DR) is a leading cause of blindness in American adults. ...For relation extraction, BERT model pretrained using general English text achieved the best strict/lenient F1-score of 0.9316. The end-to-end system, BERT_gene …
BACKGROUND: Diabetic retinopathy (DR) is a leading cause of blindness in American adults. ...For relation extraction, B …
Statins as a risk factor for diabetic retinopathy: a Mendelian randomization and cross-sectional observational study.
Chen C, Zhang H, Lan Y, Yan W, Liu S, Chen Y, Xie T, Ning J, Yan X, Shang L, Han J. Chen C, et al. J Transl Med. 2024 Mar 22;22(1):298. doi: 10.1186/s12967-024-05097-8. J Transl Med. 2024. PMID: 38520016 Free PMC article.
BACKGROUND: Diabetic retinopathy (DR) is the foremost cause of vision loss among the global working-age population, and statins are among the most frequently prescribed drugs for lipid management in patients with DR. ...METHODS: The summary-data-based Mendeli …
BACKGROUND: Diabetic retinopathy (DR) is the foremost cause of vision loss among the global working-age population, and …
Relationship between diabetic retinopathy microalbuminuria and other modifiable risk factors.
Chawla S, Trehan S, Chawla A, Jaggi S, Chawla R, Kumar V, Singh D. Chawla S, et al. Prim Care Diabetes. 2021 Jun;15(3):567-570. doi: 10.1016/j.pcd.2021.01.012. Epub 2021 Feb 4. Prim Care Diabetes. 2021. PMID: 33551334
BACKGROUND: Diabetic Retinopathy (DR) is an important microvascular complication of diabetes that can lead to irreversible blindness. ...Peripheral neuropathy was observed in 24.2% and was positively associated with DR (p = 0.002). 33.9% and 4.5% patie …
BACKGROUND: Diabetic Retinopathy (DR) is an important microvascular complication of diabetes that can lead to irreversi …
116 results